324 related articles for article (PubMed ID: 32308554)
21. Resolvins: Current understanding and future potential in the control of inflammation.
Bannenberg GL
Curr Opin Drug Discov Devel; 2009 Sep; 12(5):644-58. PubMed ID: 19736623
[TBL] [Abstract][Full Text] [Related]
22. Specialized pro-resolving mediator network: an update on production and actions.
Chiang N; Serhan CN
Essays Biochem; 2020 Sep; 64(3):443-462. PubMed ID: 32885825
[TBL] [Abstract][Full Text] [Related]
23. Specialized proresolving lipid mediators in humans with the metabolic syndrome after n-3 fatty acids and aspirin.
Barden AE; Mas E; Croft KD; Phillips M; Mori TA
Am J Clin Nutr; 2015 Dec; 102(6):1357-64. PubMed ID: 26561623
[TBL] [Abstract][Full Text] [Related]
24. The need for precision nutrition, genetic variation and resolution in Covid-19 patients.
Simopoulos AP; Serhan CN; Bazinet RP
Mol Aspects Med; 2021 Feb; 77():100943. PubMed ID: 33551236
[TBL] [Abstract][Full Text] [Related]
25. The function of specialized pro-resolving endogenous lipid mediators, vitamins, and other micronutrients in the control of the inflammatory processes: Possible role in patients with SARS-CoV-2 related infection.
Gallo CG; Fiorino S; Posabella G; Antonacci D; Tropeano A; Pausini E; Pausini C; Guarniero T; Hong W; Giampieri E; Corazza I; Loiacono R; Loggi E; de Biase D; Zippi M; Lari F; Zancanaro M
Prostaglandins Other Lipid Mediat; 2022 Apr; 159():106619. PubMed ID: 35032665
[TBL] [Abstract][Full Text] [Related]
26. DHA- and EPA-derived resolvins, protectins, and maresins in airway inflammation.
Duvall MG; Levy BD
Eur J Pharmacol; 2016 Aug; 785():144-155. PubMed ID: 26546247
[TBL] [Abstract][Full Text] [Related]
27. An update on the role of omega-3 fatty acids on inflammatory and degenerative diseases.
Lorente-Cebrián S; Costa AG; Navas-Carretero S; Zabala M; Laiglesia LM; Martínez JA; Moreno-Aliaga MJ
J Physiol Biochem; 2015 Jun; 71(2):341-9. PubMed ID: 25752887
[TBL] [Abstract][Full Text] [Related]
28. DHA/EPA (Omega-3) and LA/GLA (Omega-6) as Bioactive Molecules in Neurodegenerative Diseases.
Kousparou C; Fyrilla M; Stephanou A; Patrikios I
Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37445890
[TBL] [Abstract][Full Text] [Related]
29. An updated review of the effects of eicosapentaenoic acid- and docosahexaenoic acid-derived resolvins on bone preservation.
Jiang X; Xue Y; Mustafa M; Xing Z
Prostaglandins Other Lipid Mediat; 2022 Jun; 160():106630. PubMed ID: 35263670
[TBL] [Abstract][Full Text] [Related]
30. Resolvins as regulators of the immune system.
Seki H; Sasaki T; Ueda T; Arita M
ScientificWorldJournal; 2010 May; 10():818-31. PubMed ID: 20454764
[TBL] [Abstract][Full Text] [Related]
31. Formation of lipoxins and resolvins in human leukocytes.
Kahnt AS; Schebb NH; Steinhilber D
Prostaglandins Other Lipid Mediat; 2023 Jun; 166():106726. PubMed ID: 36878381
[TBL] [Abstract][Full Text] [Related]
32. Maresins: Specialized Proresolving Lipid Mediators and Their Potential Role in Inflammatory-Related Diseases.
Tang S; Wan M; Huang W; Stanton RC; Xu Y
Mediators Inflamm; 2018; 2018():2380319. PubMed ID: 29674943
[TBL] [Abstract][Full Text] [Related]
33. Resolvins and protectins in the termination program of acute inflammation.
Ariel A; Serhan CN
Trends Immunol; 2007 Apr; 28(4):176-83. PubMed ID: 17337246
[TBL] [Abstract][Full Text] [Related]
34. Omega-3 Polyunsaturated Fatty Acids in Critical Illness: Anti-Inflammatory, Proresolving, or Both?
Molfino A; Amabile MI; Monti M; Muscaritoli M
Oxid Med Cell Longev; 2017; 2017():5987082. PubMed ID: 28694914
[TBL] [Abstract][Full Text] [Related]
35. Omega-3 fatty acids and inflammatory processes: from molecules to man.
Calder PC
Biochem Soc Trans; 2017 Oct; 45(5):1105-1115. PubMed ID: 28900017
[TBL] [Abstract][Full Text] [Related]
36. Resolvins attenuate inflammation and promote resolution in cigarette smoke-exposed human macrophages.
Croasdell A; Thatcher TH; Kottmann RM; Colas RA; Dalli J; Serhan CN; Sime PJ; Phipps RP
Am J Physiol Lung Cell Mol Physiol; 2015 Oct; 309(8):L888-901. PubMed ID: 26301452
[TBL] [Abstract][Full Text] [Related]
37. Role of Resolvins in the Inflammatory Resolution of Neurological Diseases.
Li C; Wu X; Liu S; Shen D; Zhu J; Liu K
Front Pharmacol; 2020; 11():612. PubMed ID: 32457616
[TBL] [Abstract][Full Text] [Related]
38. Anti-inflammatory and proresolving lipid mediators.
Serhan CN; Yacoubian S; Yang R
Annu Rev Pathol; 2008; 3():279-312. PubMed ID: 18233953
[TBL] [Abstract][Full Text] [Related]
39. Novel chemical mediators in the resolution of inflammation: resolvins and protectins.
Serhan CN
Anesthesiol Clin; 2006 Jun; 24(2):341-64. PubMed ID: 16927933
[TBL] [Abstract][Full Text] [Related]
40. Natural resolution of inflammation.
Freire MO; Van Dyke TE
Periodontol 2000; 2013 Oct; 63(1):149-64. PubMed ID: 23931059
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
